Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2015-04-14
Summary
Can a combination of prenatal screening blood tests, early ultrasound, and a 3D ultrasound of the fetal face at approximately 20 weeks gestation identify fetuses with congenital anomalies and predict maternal and fetal complications?
Conditions
- Pregnancy
- Fetal Aneuploidy
Sponsors & Collaborators
-
Northwell Health
lead OTHER
Principal Investigators
-
Burton Rochelson, MD · Northwell Health
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
More Related Trials
-
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NCT04077060 ·Status: COMPLETED ·Phase: NA
-
The Role of Cytokines in Apparently Normal Pregnancies
NCT01098214 ·Status: WITHDRAWN
-
The Relationship Between Fetal Membrane Thickness and Fetal Chromosomal Aneuploidies
NCT06141213 ·Status: RECRUITING
-
Early Pregnancy Evaluation by Three-Dimensional Ultrasound
NCT00342290 ·Status: TERMINATED
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 ·Status: UNKNOWN
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Pregnancies Complicated by Fetal Anomalies
NCT02505464 ·Status: RECRUITING
-
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 ·Status: RECRUITING
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Expanded NIPT for Pregnancy Complications
NCT04311749 ·Status: COMPLETED
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597 ·Status: UNKNOWN
-
Establishing First Trimester Markers for the Identification of High Risk Twin
NCT02031393 ·Status: UNKNOWN
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities
NCT00490607 ·Status: UNKNOWN
-
The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
NCT01279369 ·Status: TERMINATED
-
Fetal Growth Evaluation by Three-Dimensional Ultrasound
NCT00340171 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT00847990 ·Status: COMPLETED
-
Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
NCT02709174 ·Status: COMPLETED